Fig. 7From: Targeting HER2-breast tumors with scFv-decorated bimodal nanoprobesIron concentration (in µg Fe/g organ) determined by atomic absorption spectrophotometry (AAS) in liver (a), spleen (b) and HER2-breast tumor (c) 24 h after the injection of SPIONs-Cy-PEG (n = 5) or SPIONs-Cy-PEG-scFv (n = 4). *p < 0.05 (Mann–Whitney test)Back to article page